Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Cadila Healthcare to report net profit at Rs. 419.9 crore down 28.9% year-on-year (down 17.8% quarter-on-quarter). Net Sales are expected to decrease by 3.6 percent Y-o-Y (down 12.4 percent Q-o-Q) to Rs. 3,134.8 crore.